Zentek (ZEN) Stock Price, News & Analysis

Company Overview

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.

Key Stats

• Today's Range: C$0.65 to C$0.69
• 50-Day Range: C$0.54 to C$1.36
• 52-Week Range: C$0.52 to C$1.70
• Volume: 93,542 shs
• Average Volume: 154,635 shs
• Market Capitalization: C$82.30 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: CVE:ZEN
• CIK: N/A
• Web: www.zentek.com
• Phone: +1-807-3461660
• Fax: N/A
• Employees: 24
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($0.09)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -C$10.75 million
• Net Margins: -5,882.61%
• Pretax Margin: N/A
• Return on Equity: -81.71%
• Return on Assets: -27.09%

Debt

• Debt-to-Equity Ratio: 19.52
• Current Ratio: 0.64
• Quick Ratio: 7.59

Sales & Book Value

• Annual Sales: C$166.05 thousand
• Price / Sales: 495.66
• Cash Flow: C$0.05 per share
• Price / Cash Flow: 13.85
• Book Value: C$0.09 per share
• Price / Book: 7.15

Miscellaneous

• Outstanding Shares: 126,620,000
• Free Float: N/A
• Market Cap: C$82.30 million
• Optionable: Not Optionable
• Beta: 0.69